Improvement of SSPE by intrathecal infusion of alpha-IFN.
Wirguin
I
I
Vander
T
T
Brenner
T
T
Abramsky
O
O
Steiner
I
I
D000293:Adolescent; D004334:Drug Administration Schedule; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage* / Q000627:therapeutic use; D015918:Infusion Pumps, Implantable; D007263:Infusions, Parenteral; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D010166:Palliative Care; D013344:Subacute Sclerosing Panencephalitis / Q000188:drug therapy*; D016896:Treatment Outcome
D007155:Immunologic Factors; D016898:Interferon-alpha